This website uses cookies to improve your experience. You can accept or reject analytics cookies
Influenza Pandemic Preparedness Plan
Pandemic Preparedness and ResponseHealth Guideline2018
EgyptEnglishPDF
National
AI-Generated Document Summary
Objectives
Egypt’s updated influenza pandemic preparedness and response plan provides a national framework to reduce morbidity, mortality, transmission and wider social and economic disruption through rapid, coordinated and evidence-informed management of pandemic influenza. It updates the 2007 plan using World Health Organization recommendations and lessons from the 2009 pandemic, recognising that future pandemics are unpredictable in timing, location, severity, transmission patterns, waves and population effects.The plan seeks to give individuals, health facilities and institutions a clear basis for joint preparedness and response, while balancing public health needs, community interests, individual rights, equity, reciprocity and solidarity.
Strengthen preparedness and regularly update plans to reflect emerging influenza strains, scientific evidence, best practice and changes in Egypt’s health system.
Maintain essential health and other basic services, minimise avoidable social and economic consequences, and support continuity planning across government, businesses, civil society and communities.
Organise action around command and control, whole-of-government and whole-of-society coordination, surveillance, laboratory services, vaccination, infection prevention and control, clinical care, communications, social distancing, research, training and evaluation.
Detect, assess and respond rapidly to novel influenza viruses through continuous local and national risk assessment, with response measures adjusted across interpandemic, alert, pandemic and transition phases.
Prevent or limit importation and early spread through border measures, contact tracing, case management and containment, then shift to mitigation when widespread transmission makes containment impractical.
Reduce pandemic impact through vaccination, antivirals, infection-control measures, clinical treatment, non-pharmaceutical interventions and protection of people at increased risk.
Support recovery through de-escalation, review of response tools and lessons, restoration of routine seasonal influenza surveillance with the pandemic subtype included, and preparation for subsequent waves.
Implementation
Implementation is led by the Ministry of Health and Population, with the Department of Epidemiology and Surveillance in the Preventive Sector playing a central coordination role.The Ministry has primary responsibility for rapid health-emergency decision-making, supported by a National Superior Committee for whole-of-government coordination, a Ministry Crisis Management Committee, and a National Pandemic Inter-Ministerial Committee acting as an incident-command group during a declared pandemic.Health Directorates report events of international concern to the Ministry, which serves as Egypt’s National Focal Point for the International Health Regulations (2005) and communicates with the World Health Organization where notification is required.
Coordinate preparedness across health, agriculture, veterinary, local development, environment, defence, interior, foreign affairs, information, finance, transport, education, communications and other relevant authorities, alongside businesses, civil society, communities and international partners.
Use regular multidisciplinary risk assessment, including the Tool of Influenza Pandemic Risk Assessment, to assess hazards, exposure and context; consider virological, epidemiological and clinical information; identify knowledge gaps; and determine proportionate phase-specific action.
Maintain nationwide surveillance through hospital-based, outpatient, sentinel, school, workplace, closed-community and event-based systems, with online reporting across governorates and health districts.Strengthen surveillance during alert and pandemic phases to monitor geographic spread, disease intensity, severity, hospitalisations, deaths, viral characteristics, antiviral sensitivity, absenteeism and societal disruption.
Operate laboratory preparedness through the Central Public Health Laboratory as the National Influenza Center, supported by subnational molecular-testing laboratories, specimen referral arrangements, staff training, quality assurance, supplies and collaboration with World Health Organization reference laboratories.
Provide daily and periodic reporting from health facilities, districts and Directorates; use weekly surveillance reports and daily hospital forms; and escalate events with pandemic potential from the Health Minister to national committees as necessary.
Prepare hospitals, primary health-care centres and private providers to sustain essential services, triage and separate suspected cases, expand beds and alternative care sites, maintain referral systems, protect workers, manage supplies and respond to increased deaths.
Maintain strategic stocks of antivirals, personal protective equipment, medicines, laboratory supplies and critical-care equipment; distribute antivirals in line with estimated cases while retaining 25% as strategic backup.
Deliver vaccine preparedness through identification of manufacturers, quality testing, cold-chain distribution, prioritisation of groups based on ethical and legal considerations, weekly uptake reporting and adverse-event monitoring.
Apply infection prevention and control through updated guidance, staff training, patient flow and isolation arrangements, personal protective equipment, safe transfers, visitor controls, occupational-health measures and surveillance of healthcare-associated infection.
Implement border health measures at international entry points through trained quarantine teams, traveller education, screening, health declarations, contact-information collection, referral, isolation and conveyance contact tracing.
Communicate transparently through trained spokespeople, hotlines, media, educators, religious and community leaders, and feedback mechanisms; support hygiene, self-isolation, reduced crowding, travel reduction, gathering restrictions and school closure where risk warrants.
Build and test operational readiness through training at all levels, simulation exercises, regular committee meetings, hospital exercises, plan reviews and corrective actions.
Monitoring & Evaluation
The plan establishes a multi-level monitoring and evaluation system centred on influenza surveillance, continuous risk assessment, routine reporting, laboratory confirmation, operational supervision and crisis-management oversight. It uses surveillance evidence to detect novel viruses, assess transmission, severity and impact, guide escalation or de-escalation of response measures, and review preparedness and control actions.
Maintain nationwide hospital-based surveillance, outpatient surveillance and sentinel surveillance for influenza-like illness and severe acute respiratory infection, supported by the National Egyptian Disease Surveillance System across 27 governorates, 270 health districts, fever hospitals and chest hospitals.
Collect, transport and test suspected-case specimens through designated laboratories, including the Central Public Health Laboratory, with polymerase chain reaction testing or virus isolation used for confirmation; monitor specimen handling and results from collection to release.
Generate weekly reports on pneumonia, avian influenza, and sentinel severe acute respiratory infection and influenza-like illness surveillance, while requiring immediate or regular reporting to senior Ministry of Health and Population officials when events with pandemic potential arise.
Require daily reporting of suspected, confirmed, complicated and fatal cases through health facilities, districts, directorates and hospitals; daily forms also track hospitalised patients, outcomes, staff absence, intensive-care and ventilator availability, bed capacity, referrals and morgue capacity.
Monitor public-health impact through hospitalisations, deaths, sickness absence, societal disruption, school and workplace absence, pharmaceutical use, and influenza-like illness signals in closed communities.
Use a threshold of influenza-like illness-related absence above 10% in a school or workplace in one governorate to notify public-health officials and trigger testing of at least two suspected cases.
Conduct event-based surveillance by screening, assessing and verifying signals from formal and informal sources, including media, health workers and non-governmental organisations.
Assess national risk continuously across interpandemic, alert, pandemic and transition phases, using virological, epidemiological and clinical information to determine response actions and phase changes.
Apply the Tool of Influenza Pandemic Risk Assessment to document threats, compare virus risks, identify knowledge gaps and inform preparedness and policy decisions; assess hazard, exposure and context, including animal infection, transmission, genomic characteristics, antiviral susceptibility, disease severity and population immunity.
Use the Pandemic Severity Index, informed by case growth, severe infection and case-fatality measures, to guide mitigation measures and social-distancing decisions.
Monitor global and regional influenza developments, genetic mutations and World Health Organization recommendations, including daily review of international outbreak information where border measures are required.
Report potential public health emergencies of international concern through established International Health Regulations processes: Health Directorates report to the Ministry of Health and Population, which serves as the National Focal Point and conducts the initial notification assessment before communicating with the World Health Organization as required.
Hold regular Risk Assessment Committee and crisis-management meetings to review findings, follow implementation of disease-control measures, communicate with the National Pandemic Inter-Ministerial Committee and World Health Organization, and address operational faults.
Monitor vaccine delivery through weekly vaccination data, track adverse events through responsible national bodies and providers, and assess vaccine safety and effectiveness.
Evaluate infection prevention and control readiness, hospital-acquired infection surveillance, hospital performance, workforce absence, clinical-guideline implementation, and facility capacity for staffing, equipment, medicines and supplies.
Conduct two major hospital exercises annually, including unannounced practical simulations, review results and deficiencies, and update hospital plans and working-group actions monthly.
Maintain structured facility, district and directorate data models recording responsible officers, staffing, beds, intensive-care capacity, ventilator competence, equipment, utilities, ambulances and potential surge areas; forms include named roles and signature fields.
Accountability is principally operational and institutional: the National Superior Committee consolidates information and follows the epidemiological situation, while the Ministry of Health and Population Crisis Management Committee provides continuous, including 24-hour, follow-up and receives hotline and crisis-centre reports.Although the plan contains substantial reporting, surveillance and review mechanisms, it does not provide a consolidated quantitative indicator framework, common performance targets, independent audit process or unified evaluation timetable.
Costing & Financing
The plan identifies extensive preparedness resource requirements and assigns some financing responsibility, but it does not provide a total costed implementation plan, monetary budget, unit costs, itemised allocations, funding-gap estimate or economic assumptions.
Provide funding through the Ministry of Finance using a pre-set budget released during health threats and emergencies, including timely financial resources to make pandemic vaccine available.
Ensure availability, redistribution and exceptional allocation of resources according to response priorities through the National Superior Committee.
Maintain strategic stocks of antivirals, personal protective equipment, medicines, vaccines, laboratory reagents, diagnostic and specimen supplies, intensive-care equipment, ventilators, monitors, pulse oximeters, ambulances and infection-control materials.
Retain 25% of released antiviral stock as a strategic backup reserve and store antivirals in dry conditions at 15°C to 30°C, with regular stability and potency testing.
Maintain a government antiviral reserve comprising 1.2 million packs of oseltamivir, raw materials for a further 1.4 million packs, a stated total availability or manufacturable capacity of 2.6 million packs, and 250,000 packs of amantadine.
Plan facility consumables qualitatively for approximately three months, including medicines, personal protective equipment, laboratory materials, disinfectants, cleaning supplies and health-education materials.
Support laboratory capacity, workforce training, public communication and hotline services, vaccine quality testing and distribution, domestic personal protective equipment production, antiviral manufacture, hospital surge sites, body refrigeration and burial services.
Recognise resource constraints affecting public mask provision and installation of hand-sanitising stations, for which available human and financial resources are reported as insufficient.
Support pandemic research through Ministry of Health and Population funding and potentially available national and international external funding opportunities; no contribution amounts are specified.
Economic consequences are recognised but not quantified: school closure may disrupt work, childcare and education, while cancellation of mass gatherings may create direct costs for organisers, hosts, sponsors and attendees and contribute to wider societal disruption.The plan therefore identifies resource needs and financing responsibilities without specifying the financial scale needed to implement them.